Nagarjuna Drugs Ltd. - Research Center
530064 NAGDRUG Group (XD) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 00 | |||||
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 5.24 | ||||
| Share application money | - | ||||
| Preference share capital | - | ||||
| Reserves & surplus | -5.76 | ||||
| Loan funds | |||||
| Secured loans | 3.47 | ||||
| Unsecured loans | 1.54 | ||||
| Total | 4.50 | ||||
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 4.32 | ||||
| Less : revaluation reserve | - | ||||
| Less : accumulated depreciation | 1.15 | ||||
| Net block | 3.18 | ||||
| Capital work-in-progress | 0.12 | ||||
| Investments | - | ||||
| Net current assets | |||||
| Current assets, loans & advances | 1.45 | ||||
| Less : current liabilities & provisions | 0.62 | ||||
| Total net current assets | 0.83 | ||||
| Miscellaneous expenses not written | 0.37 | ||||
| Total | 4.50 | ||||
| Notes: | |||||
| Book value of unquoted investments | - | ||||
| Market value of quoted investments | - | ||||
| Contingent liabilities | 4.50 | ||||
| Number of equity sharesoutstanding (Lacs) | 52.44 | ||||
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis